WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer
ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversité Catholique de Louvain
About this trial
The purpose of the study is to validate biomarkers in blood and tumor biopsy in patients with Triple Negative Breast Cancer, after a course of MitoQ treatment
Eligibility criteria
Qualifiers
Signed Informed Consent Form (ICF)
Ability to comply with protocol, in the investigator's judgment
Women aged > 18 years (no limit of age)
ECOG performance status of 0 or 1
Disqualifiers
Men
Prior systemic therapy for treatment and prevention of the current breast cancer
Known allergy or hypersensitivity to MitoQ
Known active viral hepatitis
Trial design
Treatments tested in this trial
- MitoQ (mitoquinol mesylate)
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov